[Article] Trends for 2026 in Quality and Patient Safety
Trends for 2026 in Quality and Patient Safety
In 2026, patient safety is no longer treated merely as a regulatory requirement and assumes a central role in healthcare organisations’ strategic agendas. In the face of increasing clinical complexity, pressure for efficiency, and the growing use of data, automation and artificial intelligence, more mature institutions are evolving towards performance-driven models, continuous learning and structured governance.
Epimed Monitor Patient Safety supports this transformation by integrating incident management, indicators and organisational learning, enabling safer, evidence-based clinical and executive decision-making.
Key topics
- Learning-oriented organisations that transform incidents into real improvement;
- Workforce wellbeing as a technical factor in patient safety;
- Expansion of hybrid care models and new risk scenarios;
- Cybersecurity as a direct component of patient safety;
- Data quality and interoperability as the foundation for safe decisions.
In 2026, healthcare quality and patient safety definitively cease to be treated as support functions or mere instruments of regulatory compliance. They move to the centre of organisational strategy, influencing clinical, operational and executive decisions. This landscape is shaped by increased clinical complexity, workforce shortages, pressure for efficiency and the growing adoption of advanced technologies, particularly data, automation and artificial intelligence (AI).
For clinicians, managers and executives, understanding these trends is not simply a matter of technical updating, but a determining factor for care sustainability, risk reduction and organisational resilience. The following sections highlight the key themes expected to shape the quality and patient safety agenda in 2026.
Patient safety as an organisational performance system
The primary conceptual shift for 2026 is the transition of patient safety from a set of isolated protocols to an integrated organisational performance system. Indicators are no longer viewed merely as periodically reported figures, but as tools that guide strategic decisions, risk prioritisation and resource allocation.
This shift is reinforced by international guidance, such as the adoption of measurable performance goals in place of generic objectives, as seen in frameworks developed by accreditation bodies like The Joint Commission. The focus moves towards objective evidence, including sustained adherence to critical processes, reduction of clinical variability and continuous demonstration of improvement over time.
To read the complete material, download the file.
